Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
padeliporfin (Tookad) (1 trial)
bevacizumab (avastin) (3 trials)
capecitabine (xeloda) (2 trials)
cyclophosphamide (cytoxan) (2 trials)
docetaxel (taxotere) (2 trials)
doxorubicin (Doxil) (1 trial)
epirubicin (ellence) (1 trial)
irinotecan (Camptosar) (1 trial)
oxaliplatin (eloxatin) (1 trial)
pertuzumab (perjeta) (1 trial)
trastuzumab (herceptin) (2 trials)
trastuzumab emtansine (kadcyla) (1 trial)
sodium chloride (1 trial)
t4p1001 (1 trial)
Breast Neoplasms (Phase 2)
Colorectal Neoplasms (Phase 2)
Enuresis (Phase 4)
Erectile Dysfunction (Phase 4)
Prostatic Neoplasms (Phase 4)
Urinary Incontinence (Phase 4)
Trials (6 total)
Trial APIs (14 total)